Transaction DateRecipientSharesTypePriceValue
15th September 2020Capital Vi Fcpr Sofinnova9,261Open or private sale$13.16$121,912.73
15th September 2020Capital Vi Fcpr Sofinnova32,336Open or private sale$12.45$402,563.80
9th September 2020Group, Llc Redmile8,650Open or private purchase$51.85$448,523.26
9th September 2020Group, Llc Redmile14,610Open or private purchase$52.96$773,811.35
8th September 2020Bros. Advisors Lp Baker15,807Open or private purchase$47.04$743,482.25
8th September 2020Bros. Advisors Lp Baker6,151Open or private purchase$47.39$291,479.90
8th September 2020Bros. Advisors Lp Baker76,473Open or private purchase$47.39$3,623,856.64
8th September 2020Bros. Advisors Lp Baker1,272Open or private purchase$47.04$59,828.52
8th September 2020Bros. Advisors Lp Baker15,172Open or private purchase$47.47$720,199.67
8th September 2020Bros. Advisors Lp Baker1,220Open or private purchase$47.47$57,912.18
Hookipa Pharma
Hookipa Pharma logo

HOOKIPA Pharma, Inc. engages in the development of immunotherapeutics, targeting infectious diseases and cancers. Its product include VaxWace, a replication-deficient viral vector. The company was founded by Rolf Zinkernagel in 2011.

Ticker: HOOK
Sector: Healthcare
Industry: Biotechnology
SEC Central Index Key (CIK): 1760542
Employees: 56
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals